9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Operating Expenses | 42,017 | 36,762 | 60,878 | 25,549 | 18,224 |
| Operating Income | -42,017 | -36,762 | -60,878 | -25,549 | -18,224 |
| Interest Expense | 2,667 | 47 | 4,046 | 1,825 | 6,152 |
| Other Income | 918 | 30 | 3,428 | 325 | 214 |
| Pre-tax Income | -43,766 | -36,779 | -61,497 | -27,049 | -24,162 |
| Net Income Continuous | -43,766 | -36,779 | -61,497 | -27,049 | -24,162 |
| Net Income | $-43,766 | $-36,779 | $-61,497 | $-27,049 | $-24,162 |
| EPS Basic Total Ops | -3.38 | -3.03 | -11.60 | -16.20 | -19.60 |
| EPS Basic Continuous Ops | -3.38 | -3.03 | -11.64 | -16.23 | -19.52 |
| EPS Diluted Total Ops | -3.38 | -3.03 | -11.60 | -16.20 | -19.60 |
| EPS Diluted Continuous Ops | -3.38 | -3.03 | -11.64 | -16.23 | -19.52 |
| EPS Diluted Before Non-Recurring Items | -3.38 | -3.00 | -11.60 | N/A | -19.60 |
| EBITDA(a) | $-40,177 | $-36,710 | $-59,340 | $-24,460 | $-15,691 |